IgG4 Related Disease (IgG4 RD) treatment in Istanbul — get 3 personalized clinic matches

Professor of Medical Oncology with a focus on Gastrointestinal Oncology – Prof. Sağlam brings specialized expertise to IgG4 RD cases at Gayrettepe Florence Nightingale Hospital.

• Over 15 years of experience in medical oncology
• Fellowship-trained at Istanbul University – a leading medical institution
• Member of ESMO and ASCO – top oncology societies
• Specialized in gastrointestinal oncology since 2005

Prof. Dr. Sefik Igdem specializes in advanced radiation oncology at Gayrettepe Florence Nightingale Hospital.

• Experienced in treating head and neck cancers
• Uses advanced technologies like Truebeam Stx
• Professor at T.R. Demiroğlu Bilim University
• Specializes in conformal treatments for precision

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.